--- title: "BIAFW.US (BIAFW.US) — 相關新聞" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/BIAFW.US/news.md" symbol: "BIAFW.US" name: "BIAFW.US" parent: "https://longbridge.com/zh-HK/quote/BIAFW.US.md" datetime: "2026-03-13T20:51:01.153Z" locales: - [en](https://longbridge.com/en/quote/BIAFW.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/BIAFW.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/BIAFW.US/news.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/BIAFW.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/BIAFW.US/news.md) # BIAFW.US (BIAFW.US) — 相關新聞 ### [Crude Oil Gains Over 1%; VEON Shares Spike Higher](https://longbridge.com/zh-HK/news/279074967.md) *2026-03-13T17:01:34.000Z* > U.S. stocks mostly declined, with the Nasdaq down 0.71% and the Dow up 0.03%. Utilities rose 1.2%, while communication s ### [BUZZ-U.S. STOCKS ON THE MOVE-Carvana, Circle, Voyager Acquisition Corp](https://longbridge.com/zh-HK/news/279074124.md) *2026-03-13T16:55:28.000Z* ### [bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth](https://longbridge.com/zh-HK/news/279062229.md) *2026-03-13T14:30:16.000Z* > bioAffinity Technologies Inc (NASDAQ:BIAF) shares surged 124.30% to $2.40 after reporting FY25 results, highlighting an ### [](https://longbridge.com/zh-HK/news/279059950.md) *2026-03-13T13:04:05.000Z* > bioAffinity Technologies shares are trading higher after the company reported FY25 financial results. ### [BIOAFFINITY TECHNOLOGIES INC C/WTS 07/09/2027 (TO PUR COM) | 8-K: FY2025 Revenue: USD 6.162 M](https://longbridge.com/zh-HK/news/279043994.md) *2026-03-13T12:32:44.000Z* ### [](https://longbridge.com/zh-HK/news/278572333.md) *2026-03-10T13:58:49.000Z* > bioAffinity Technologies shares are trading higher after the company announced initiation of a large-scale, longitudinal ### [bioAffinity Launches Major Lung Cancer Detection Study](https://longbridge.com/zh-HK/news/278565253.md) *2026-03-10T13:25:00.000Z* > bioAffinity Launches Major Lung Cancer Detection Study ### [bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic | BIAF Stock News](https://longbridge.com/zh-HK/news/278548760.md) *2026-03-10T03:50:36.000Z* > bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lun ### [bioAffinity Showcases Sputum-Based Platform for Personalized Asthma Care](https://longbridge.com/zh-HK/news/277701323.md) *2026-03-04T01:01:30.000Z* > bioAffinity Technologies, Inc. (BIAF) showcased its sputum-based diagnostic platform for personalized asthma care at the